异动解读 | 莫德纳公司盘前股价大跌10.63%,由于RSV疫苗滞后上市及COVID疫苗销售疲软导致2025年销售预期下调

异动解读
13 Jan

莫德纳公司周一盘前股价大跌10.63%,引起市场广泛关注。

公司当日宣布,将2025年的销售预期从之前的25亿至35亿美元下调至15亿至25亿美元,主要原因是呼吸道合胞病毒(RSV)疫苗上市进程缓慢,以及新冠肺炎疫苗需求低于预期。

为加速增长,莫德纳正着手新产品的开发,包括已向美国FDA申请批准的COVID-19和流感联合疫苗等。公司预计今年将公布针对季节性流感疫苗的试验数据。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10